- Home
- News
- latamerica
- hemodynamics data
Hemodynamics Data Articles & Analysis
11 news found
Our latest publication in Cardiovascular Engineering and Technology showcases the feasibility and functionality of our VCAST technology, a patented, AI-based medical system developed for non-invasive, clinical quantitative and qualitative analysis of CT-scan data, to assess the hemodynamic significance of coronary artery atherosclerotic stenosis. ...
The technology is intended to be convenient and requires only 20 seconds each morning, and should easily lend itself to integration into a daily routine. The device can transmit the data on cardiac hemodynamic parameters to clinicians through cellular networks, and uses AI-based algorithms to identify a variety of hemodynamic biomarkers to aid ...
Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced positive data from the SIRONA 2 clinical trial evaluating safety and efficacy of its Cordella™ Pulmonary Artery Pressure Sensor System (Cordella Sensor) in New York Heart Association (NYHA) class III heart failure patients. ...
Following the 2021 update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment and the recently presented GUIDE-HF data, the FDA’s decision underscores the clinical benefits of PA pressure-guided HF management for New York Heart Association (NYHA) class III heart failure patients2,3. ...
The publication entitled“First Clinical Experience With the Pressure Sensor–Based Autoregulation of Blood Flow in an Artificial Heart” details the reliability and efficacy of the Aeson’s autoregulation control mechanism (auto-mode), designed to mimic normal physiologic responses to changing patient needs. Hemodynamic data from a cohort of ...
ByCarmat
Additional new data demonstrate that an evaluation of hand tremor can be performed via telemedicine appointment to prescribe Cala Trio, the company noted. ...
“I have had the pleasure of following the team’s progress and am impressed by the growing data demonstrating the value of the Cordella System,” commented Mr. ...
“Together our Cordella Sensor and Cordella System provide a robust platform for data-guided chronic disease management based on changes in pulmonary artery (PA) pressure, an early indicator of worsening heart failure,” said Michael Nagy, Chief Technology Officer at Endotronix. ...
The system provides a comprehensive health status of the patient at home with easy-to-use tools to securely collect and share health-related data with healthcare providers for trend-based management. The Cordella Sensor seamlessly integrates pulmonary artery (PA) pressure data into the Cordella System. ...
Mullens commented, “The current treatment model for chronic heart failure is reactive and costly. Clinical data demonstrates that pulmonary artery (PA) pressure is the best indicator for early detection and proactive care of heart failure decompensation,” Prof. ...
“We’re entering a pivotal phase for the company that will produce commercial success and clinical data that accelerates our market adoption. I look forward to working with the team and executing on our ...